Delivery Order SPE2DB22D2211-SPE2DB25FSDBD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units, with a contract ceiling value of $1,460.44 and an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open procurement process. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Erythromycin 0.5% Eye Ointment in 3.5-gram units, with a ceiling value of $2,247.57. This competitively awarded, firm fixed-price delivery order was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract contains no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This competitive, non-set-aside contract has a ceiling value of $2,675.15 and was awarded on July 29, 2025, with an ultimate completion date of July 30, 2025. The contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,588.31 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This is a firm fixed-price delivery order with a completion date of September 11, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,499.80 to AmerisourceBergen Drug Corp for erythromycin 0.5% eye ointment, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen Drug Corp's larger pharmaceutical supply relationship with DLA....
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units under a firm fixed-price contract valued at $1,716.53. The order was competitively awarded without a set-aside designation and is scheduled for completion by August 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order. This delivery order is...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This firm fixed-price delivery order, valued at $1,888.66, represents a competitive award with no set-aside designation and carries an ultimate completion date of September 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,945.13 to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5-gram units. This firm fixed price contract, awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, represents a straightforward pharmaceutical procurement executed through AmerisourceBergen's existing contract vehicle with DLA. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Erythromycin 0.5% Eye Ointment. This firm fixed price delivery order, valued at $2,475.20, represents a non-set-aside competitive award and is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a $1,329.43 delivery order to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% eye ointment. The contract, which is not set-aside and carries a firm fixed price structure, was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025. Performance will be executed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDBDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Erythromycin 0.5% Eye Ointment in 3.5 gram units. This contract, valued at $5,328.34, was competitively awarded without a set-aside designation and carries a firm fixed price structure. The award was executed on August 18, 2025, with an ultimate completion date of August 19, 2025. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs through its extensive portfolio of contracts with the Defense Logistics Agency and its Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 8/18/25 |